Epidemiologic data have linked IP6K1, the major IP6K isoform, to obesity in humans [30], and genetics-based studies have identified the kinase as a critical driver of metabolic disease, insulin resistance, and fatty liver in rodent models of DIO. Here, IP6K1 is linked to Insulin resistance.